Plain-English translation of NCT07081074 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new cream made from amino acids and designed to protect your skin during radiation therapy for head and neck cancer. The medication works by neutralizing harmful molecules (called reactive oxygen species) that radiation creates, which damage healthy skin cells. Researchers hope this treatment will help prevent the painful skin burns and damage that often occur during head and neck cancer radiation.
Severe skin damage is one of the most common and difficult side effects of radiation therapy for head and neck cancer, and it often forces patients to pause or interrupt their treatment. Current ways to prevent this damage don't work well enough, so this trial is testing whether this new medication can offer better protection and help patients complete their cancer treatment without interruption.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the new cream alongside standard care or to receive standard care alone. You will apply the cream to the skin in your treatment area during your radiation therapy course. Researchers will monitor your skin closely during and after your radiation treatment to see whether the medication reduces skin damage compared to standard care alone.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China